This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

MDC Associates Sets New Standard in Clinical Trial Management for In Vitro Diagnostics

MDC Associates, a consultancy specializing in regulatory, quality, and clinical solutions for in vitro diagnostics (IVDs) and medical devices, is working to reshape the landscape of clinical trial management.

-- MDC Associates, a consultancy specializing in regulatory, quality, and clinical solutions for in vitro diagnostics (IVDs) and medical devices, is working to reshape the landscape of clinical trial management. With over 35 years of expertise and a proven track record of supporting over 700 IVD and MedTech clients worldwide, the company is setting a new benchmark for excellence in navigating the complex process of bringing diagnostic innovations to market.

The demand for reliable and efficient clinical trial management continues to grow as the healthcare industry advances. For IVD and medical device companies, ensuring compliance with regulatory standards while expediting time-to-market is critical. MDC Associates is meeting this challenge with a comprehensive suite of services tailored to the unique needs of IVD manufacturers. By offering strategic guidance and hands-on support, the company is helping innovators transform groundbreaking ideas into life-saving products.

MDC Associates’ clinical trial management services cover every process stage, from initial study design to final reporting. This includes developing clinical, analytical, and usability study protocols that adhere to stringent regulatory requirements. The firm identifies and qualifies study sites, manages contracts, and oversees Institutional Review Board (IRB) processes, ensuring studies are conducted efficiently and ethically. Through meticulous study monitoring, data management, and analysis, MDC delivers actionable insights and robust documentation that facilitate smooth regulatory submissions.

The firm’s expertise spans various diagnostic applications, including microbiology, infectious diseases, clinical chemistry, oncology, and companion diagnostics. Its experience with diverse technologies such as molecular diagnostics, next-generation sequencing, mass spectrometry, and digital imaging positions MDC Associates as a trusted partner for companies developing cutting-edge solutions. This broad technical knowledge enables the firm to anticipate challenges and devise strategies that mitigate risks, optimize resources, and maintain compliance with regulatory standards.

MDC Associates’ success in clinical trial management is reflected in its impressive track record. The company has conducted over 100 clinical studies across the United States and Europe, managed over 140 FDA submissions, and supported approximately 520 FDA Q-submissions annually. This extensive experience gives clients confidence in their regulatory journey, knowing that every detail is handled with precision and expertise.

Regulatory compliance is a cornerstone of clinical trial management, and MDC Associates excels in navigating the complex regulatory landscape. The firm’s services include preparing comprehensive submission packages for 510(k), De Novo, and PMA applications and obtaining CE/IVDR certifications for European markets. Its expertise in FDA Breakthrough Device Designation and Q-submission management further underscores its ability to secure timely regulatory approvals for innovative diagnostics.

As the healthcare industry evolves, MDC Associates remains at the forefront of clinical trial management for IVDs. The firm’s commitment to innovation, excellence, and client success has established it as a leader in the field. MDC is playing a vital role in advancing healthcare by guiding diagnostic companies through the regulatory maze and helping them bring their products to market efficiently.

MDC Associates is headquartered in Boston, with consultants strategically located across the United States and Europe to provide localized support. For more information on the company’s clinical trial management services and other offerings, visit http://mdcassoc.com

About MDC Associates:

MDC provides life-saving diagnostic makers with the right support and catered solutions needed to make our world a healthier place. With over 35 years of experience, MDC Associates has the experience and expertise to provide unparalleled regulatory strategy and execution, full-service CRO planning and study management, quality systems design and implementation, and data management support, guidance, and analysis. Located on the technology corridor north of Boston, Massachusetts, MDC has earned a reputation of trust with companies of all sizes that develop, manufacture, and distribute in vitro diagnostic tests and instruments. The unique way MDC focuses its work and counsel guides clients in demonstrating safety and efficacy to achieve product approval, making MDC a valuable partner on the path to commercial success.



About the company: MDC provides life-saving diagnostic makers with the right support and catered solutions needed to make our world a healthier place. With over 35 years of experience, MDC Associates has the experience and expertise to provide unparalleled regulatory strategy and execution, full-service CRO planning and study management, quality systems design and implementation, and data management support, guidance, and analysis.

Contact Info:
Name: Kevin Roy
Email: Send Email
Organization: GreenBanana
Website: http://www.greenbananaseo.com

Release ID: 89163110

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.